A group based on complementary expertise with multidisciplinary know-how

A range of integrated biotechnology solutions

A complete platform, from DNA to recombinant antibodies

News

Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.

Date of publication : 21/08/2018

Le Projet MiMédi

MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

Au sein de ce consortium, Diaclone apporte son expertise et son savoir-faire de plus de 30 ans dans le domaine des anticorps, afin d’aider à la mise en place de processus novateur en matière de tri cellulaire, de détection de contamination, de suivi de populations cellulaires, etc…

    

 

Pour plus d'information cliquez ici

  • Festival Of Biologics congress
    RD-Biotech will be present at the Festival of Biologics congress! Organized by Terrapinn from November 9 to 11, 2021
    Date of publication : 25/10/2021

    This congress will take place in Basel (CH)

    RD-Biotech will be exhibiting, alongside Mabdesign. We will be delighted to welcome you on our stand to discuss with you our biomanufacturing services...

    Read more
  • RD-Biotech: laureate “France Relance, volet Résilience”
    Date of publication : 04/10/2021

    On Thursday 30 September 2021, RD-Biotech was pleased to welcome Mr Jean-François Colombet, Prefect of the Doubs, as part of the France Relance plan, Résilience category.


    Selected...

    Read more
  • Custom antibody biomanufacturing & Autumn discounts
    Date of publication : 13/09/2021
    Contact us for more information! Read more
  • RD-Biotech will participate to the first edition of the Innovative Therapies Days, on October 14 and 15, 2021 in Besancon
    Date of publication : 09/09/2021

    First edition of Innovative Therapies Days on 14 and 15 October 2021 in Besancon (25-France) organized by Innov'Health! The meeting of local and international companies specialized in...

    Read more
  • A new website for RD-Biotech
    Date of publication : 23/08/2021

    We are pleased to inform you that RD-Biotech has launched a brand-new website!

    Find here all of the custom development and biomanufacturing services for plasmids, antibodies, recombinant proteins...

    Read more
  • Biotech Investissement Holding sells its affiliate Diaclone SAS (France) to Medix Biochemica (Finland)
    Date of publication : 15/07/2021

    Biotech Investissement will reinforce its business in the biomanufacturing market and molecular engineering services and sells its affiliate Diaclone SAS to Medix Biochemica. The arrival of Diaclone...

    Read more
  • Diaclone ELISpot assays, tried and trusted by researchers worldwide
    Date of publication : 01/04/2021


    Diaclone ELISpots (Enzyme-Linked Immunospot Assays) are highly specific immunoassays for the analysis of cytokine and other soluble molecule production and secretion from T-cells at a single cell...

    Read more
  • Come and join our team!
    Date of publication : 11/03/2021

    As part of the development of its new GMP plasmid production unit, RD-Biotech is recruiting two new profiles:

    - Technician in Molecular Biology Bioproduction

    - Quality Control Manager

    For...

    Read more
  • Diaclone is a partner in a major European project involving a dozen partners from the Besançon region.
    Date of publication : 21/08/2018

    Le Projet MiMédi

    MIMEDI: MIcrotechnique pour les MEDicaments Innovants nouvelles solutions technologiques pour optimiser la fabrication de "cellules médicaments"

    Au sein...

    Read more